Table 2.
Distribution of KIR genotypes in patients with AML compared to controls.
| KIR genotypes | AML: n = 181 (%) | Control: n = 181 (%) | P-value OR (95% CI) |
|---|---|---|---|
| AA | 39 (21.6) | 42 (23.2) | 0.70 |
| Bx | 142 (78.4) | 139 (76.8) | |
| Bx genotype subsets | n = 142 (%) | n = 139 (%) | |
| C4T4 | 18 (12.7) | 12 (8.6) | 0.27 |
| C4Tx | 36 (25.4) | 46 (33.1) | 0.15 |
| CxT4 | 31 (21.8) | 17 (12.2) | 0.03 |
| 2 (1.05–3.82) | |||
| CxTx | 57 (40.1) | 64 (46) | 0.31 |
| C4 cluster | 54 (38.1) | 58 (42) | 0.52 |
| T4 cluster | 49 (34.5) | 29 (20.8) | 0.01 |
| 1.99 (1.17–3.41) |
The Chi-square test was done based on a 2 × 2 contingency table, p < 0.05 was considered significant. OR: odds ratio, CI: confidence interval.
Significant values are in bold.